AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 132 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,874,000 | +59.8% | 55,990 | 0.0% | 0.76% | +54.2% |
| Q3 2019 | $1,173,000 | -1.9% | 55,990 | -2.6% | 0.49% | -2.4% |
| Q2 2019 | $1,196,000 | -2.8% | 57,456 | +4.4% | 0.50% | +2.9% |
| Q1 2019 | $1,231,000 | -2.6% | 55,056 | +4.2% | 0.49% | -17.3% |
| Q4 2018 | $1,264,000 | +5.0% | 52,857 | +19.7% | 0.59% | +51.9% |
| Q3 2018 | $1,204,000 | +9.8% | 44,152 | +8.3% | 0.39% | -4.9% |
| Q2 2018 | $1,097,000 | +15.7% | 40,780 | +36.9% | 0.41% | +5.1% |
| Q1 2018 | $948,000 | +211.8% | 29,780 | +270.8% | 0.39% | +223.1% |
| Q4 2017 | $304,000 | +508.0% | 8,031 | +301.6% | 0.12% | +476.2% |
| Q3 2017 | $50,000 | – | 2,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |